Prevention of stroke in elderly patients with a trial fibrillation: possibilities of Apixaban
In review article, we discuss the opportunity of use of one of the direct oral anticoagulants – apixaban – for prevention of stroke and/or systemic embolism in elderly patients with non-valvular a trial fibrillation. We consider results of randomized clinical trials of apixaban – ARISTOTLE and AVERR...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SSFIMT
2020-05-01
|
| Edice: | Российский журнал гериатрической медицины |
| Témata: | |
| On-line přístup: | https://www.geriatr-news.com/jour/article/view/34 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|